Factors related to hypermetabolism in individuals with type 2 diabetes mellitus and non-alcoholic fatty liver disease
- PMID: 36871124
- PMCID: PMC9985614
- DOI: 10.1038/s41598-023-30945-w
Factors related to hypermetabolism in individuals with type 2 diabetes mellitus and non-alcoholic fatty liver disease
Abstract
Considering the progressive prevalence and co-occurrence of type 2 diabetes mellitus (T2DM) and non-alcoholic fatty liver disease (NAFLD), as well as the current evidence suggesting the elevated levels of basal metabolic rate (BMR) among these individuals, the present study aimed to identify factors determining hypermetabolism in such subjects. This cross sectional study was conducted in 30 to 53-year-old individuals with concurrent T2DM and NAFLD (controlled attenuation parameter score ≥ 260 dB/m). Resting energy expenditure (REE) was determined by an indirect calorimetry device. Hypermetabolism was defined as an elevated measured REE > 110% of the predicted REE. The multivariate logistic regression test was used for detecting factors associated with hypermetabolism. Between September, 2017, and March, 2018, a total of 95 eligible participants (64.40% male) with both T2DM and NAFLD were included, while 32.63% of them were classified as hypermetabolic. Overall, the mean recruitment age ± standard deviation and median (interquartile range) body mass index were 44.69 ± 5.47 years and 30.20 (27.80-33.30) kg/m2, respectively. Demographic, anthropometric and biochemical variables did not vary significantly across two groups except for total body water, low-density lipoprotein cholesterol and dipeptidyl peptidase 4 (DPP-4) inhibitors (p < 0.05). According to the results of multivariable logistic regression analyses, hypermetabolism had a positive association with adiponectin (odds ratio [OR] 1.167, 95% confidence interval [CI] 1.015-1.342, p = 0.030), physical activity (OR 1.134, 95% CI 1.002-1.284, p = 0.046), alanine transaminase (OR 1.062, 95% CI 1.006-1.122, p = 0.031) and diastolic blood pressure (OR 1.067, 95% CI 1.010-1.127, p = 0.021). However, fat free mass was inversely related to hypermetabolism (OR 0.935, 95% CI 0.883-0.991, p = 0.023). Adiponectin, alanine transaminase, physical activity, diastolic blood pressure and fat free mass were independently associated with hypermetabolism in subjects with NAFLD and T2DM.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Similar articles
-
The Relationship between Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease Measured by Controlled Attenuation Parameter.Yonsei Med J. 2016 Jul;57(4):885-92. doi: 10.3349/ymj.2016.57.4.885. Yonsei Med J. 2016. PMID: 27189281 Free PMC article.
-
Screening for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography.J Gastroenterol Hepatol. 2019 Aug;34(8):1396-1403. doi: 10.1111/jgh.14577. Epub 2019 Jan 21. J Gastroenterol Hepatol. 2019. PMID: 30551263
-
[Non-alcoholic fatty liver disease increases the incidence rate of type 2 diabetes mellitus: a cohort study based on a rural town elderly population of southern Jiangsu].Zhonghua Gan Zang Bing Za Zhi. 2021 Sep 20;29(9):867-872. doi: 10.3760/cma.j.cn501113-20200429-00223. Zhonghua Gan Zang Bing Za Zhi. 2021. PMID: 34638206 Chinese.
-
Effect of SGLT2 Inhibitors on Type 2 Diabetes Mellitus With Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials.Front Endocrinol (Lausanne). 2021 Jun 17;12:635556. doi: 10.3389/fendo.2021.635556. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34220701 Free PMC article.
-
Non-Alcoholic Fatty Liver Disease Treatment in Patients with Type 2 Diabetes Mellitus; New Kids on the Block.Curr Vasc Pharmacol. 2020;18(2):172-181. doi: 10.2174/1570161117666190405164313. Curr Vasc Pharmacol. 2020. PMID: 30961499 Review.
Cited by
-
Serum stromal cell-derived factor-1 concentrations are increased and associated with nonalcoholic fatty liver disease in children with obesity.BMC Endocr Disord. 2024 May 10;24(1):67. doi: 10.1186/s12902-024-01597-2. BMC Endocr Disord. 2024. PMID: 38730413 Free PMC article.
-
Redefining Nutritional Requirements in End-Stage Liver Disease: Towards a Personalized Approach.Nutrients. 2023 Nov 13;15(22):4770. doi: 10.3390/nu15224770. Nutrients. 2023. PMID: 38004164 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous